Clinical Trial

REGistry of Long-term AnTithrombotic TherApy-2

Name: REGistry of Long-term AnTithrombotic TherApy-2 — clinical trial record (NCT04347187)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: REGATTA-2

Recruiting

View on ClinicalTrials.gov →

Summary

To assess the rates of ischemic and hemorrhagic complications of long-term antithrombotic therapy in patients with atrial fibrillation

Protocol Amendment History 3 amendments

This ClinicalTrials.gov record has been amended 3 times since 2020-04-14; most recent amendment 2026-04-27.

Trial Details

NCT Number	NCT04347187
Lead Sponsor	National Medical Research Center for Cardiology, Ministry of Health of Russian Federation
Conditions	Atrial Fibrillation
Enrollment	2,000 participants
Start Date	2015-01-15
Primary Completion	2026-12-31 (estimated)
Study Completion	2026-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-05-01